Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.

about

Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.

Item

http://www.wikidata.org/entity/Q47825877

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tumor recurrence versus treatm ...... sceptibility contrast imaging.

@en

Tumor recurrence versus treatm ...... sceptibility contrast imaging.

@nl

type

Item

label

Tumor recurrence versus treatm ...... sceptibility contrast imaging.

@en

Tumor recurrence versus treatm ...... sceptibility contrast imaging.

@nl

prefLabel

Tumor recurrence versus treatm ...... sceptibility contrast imaging.

@en

Tumor recurrence versus treatm ...... sceptibility contrast imaging.

@nl

P1476

Tumor recurrence versus treatm ...... sceptibility contrast imaging.

@en

P2093

Haitao Ge

http://www.w3.org/2001/XMLSchema#string

Jiangfen Wu

http://www.w3.org/2001/XMLSchema#string

Jianxun Qu

http://www.w3.org/2001/XMLSchema#string

Kai Xu

http://www.w3.org/2001/XMLSchema#string

Qi Liu

http://www.w3.org/2001/XMLSchema#string

Qian Xu

http://www.w3.org/2001/XMLSchema#string

Xinting Ge

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Clinical applications of intracranial perfusion MR imaging.

Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity.

Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.

The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence

Post-treatment imaging changes in primary brain tumors.

Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction.

Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging

Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.

Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.

P304

e9332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000009332

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29390403

http://www.w3.org/2001/XMLSchema#string

P932

5815815

http://www.w3.org/2001/XMLSchema#string